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I read with great interest the editorial recently published in the British Journal of Anaesthesia that 
questioned whether sedation by non-anaesthetists is really safe.1 The authors noted their ‘grave 
concerns’ about the emerging practice of non-anaesthetist administered propofol (NAAP) during 
electrophysiology procedures. I offer the following insights into this issue.  
One considerably important factor driving the emergence of this practice did not seem to be 
adequately considered in this editorial. Yet, I believe it deserves to be highlighted. One rationale 
behind using NAAP during electrophysiology procedures is that: 1) gaining access to monitored 
anaesthesia care for sedation in the cardiac catheterisation laboratory is difficult in many institutions 
around the world2, 3; 2) propofol might outperform the current standard practice sedative and 
analgesic medication regimen that is used during electrophysiology without an anaesthetist present, 
which consists of a benzodiazepine/opioid combination, because its shorter half-life could 
potentially reduce recovery time (and as a result, healthcare resource costs)4 and its rapid onset of 
action might result in increased patient satisfaction with the procedural experience; and 3) adverse 
events associated with the use of NAAP in other procedural settings is rare.5 Of note, though, while 
safety data reported in the preliminary studies focused on NAAP outcomes during electrophysiology 
is encouraging, future research in this field must utilise more rigorous research designs in order to 
determine whether NAAP actually is the superior sedation strategy, considering the issues 
highlighted above.6-8 In this regard, randomised controlled trials comparing NAAP with Anaesthetist-
administered sedation as well as the current standard practice nurse-administered sedative and 
analgesic medication regimen which consists of a benzodiazepine/opioid combination should be 
considered. 
Yet, instead of taking an ‘us against them’ perspective, it would be more beneficial to our future 
patients if NAAP research in the electrophysiology context always involved truly collaborative 
ventures between cardiologists and nurses as well as anaesthesiologists. A multidisciplinary 
approach, incorporating specialist knowledge from anaesthesiologists for the development of 
protocols for medication titration and patient monitoring as well as comprehensive education 
programs, would ensure the cardiologists and nurses involved in the provision of patient care during 
NAAP posses the necessary knowledge and skills to promptly detect clinical deterioration and 
effectively apply interventions to support or restore cardiac and respiratory function. From a quick 
search of authors’ affiliations it does not seem that the current research into NAAP during 
electrophysiology has managed to achieve such multidisciplinary collaboration.6-8 
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